Precision Medicine

Amgen, Merck, Roche get in on Syapse’s $30M round

November 16, 2017

by Amirah Al Idrus Syapse picked up $30 million in series D financing, funds it will use to bring its oncology precision medicine software to more healthcare providers. In addition to its oncology software platform, which enables caregivers in large health systems to practice precision medicine consistently, Syapse offers a data-sharing network. This provides physicians […]

Facilitating a drug discovery ecosystem: Genestack joins the Milner Therapeutics Institute

October 30, 2017

“As sequencing technology shrinks to the size of a key ring and emerging technologies make it possible to track changes to the genome at single cell level, then all of a sudden genomics data becomes a streaming and wearable dataset,” says Imad Yassin, Vice President of bio data management company Genestack. He is explaining why […]

Certara-Monash University Industry Fellowship Program Receives Funding from MTPConnect’s Project Fund Program

October 26, 2017

Fellowship program recognised as a big, bold idea to improve the productivity, competitiveness and innovative capacity of Australia’s medtech, biotech and pharmaceutical sector MTPConnect – the Medical Technologies and Pharmaceuticals Industry Growth Centre – today announced it will provide a proposed AUD750,000 provisional funding to the Certara-Monash University Industry Fellowship Program over two years, with […]

Elsevier announces winners of the 2017 Reaxys PhD Prize

October 25, 2017

Three young chemistry researchers recognized for their innovative and original research Elsevier, the information analytics business specializing in science and health, announced the three winners of the 2017 Reaxys PhD Prize at its annual Symposium held in Shanghai, China. Celebrating top research by leading young chemists across the globe, the Reaxys PhD Prize recognizes innovative […]

BioIVT Expands Its Support for Precision Medicine Researchers

October 25, 2017

BioIVT is sponsoring the Powering Precision Health Summit 2017 and showcasing its precision medicine product and services portfolio BioIVT, a leading provider of biospecimens and related services, today announced that it is sponsoring the Powering Precision Health Summit (PPHS) 2017. This conference will bring together leaders in biomarker research and translational medicine to present the […]

Laboratory Informatics Leaders to Gather in Philadelphia

October 24, 2017

Philadelphia, PA  (October 20)  IQPC’s  14th Laboratory Informatics Summit, the nation’s foremost event addressing innovative solutions to leverage the modern lab will take place in Philadelphia, PA, this December 4-6, 2017. This summit will focus on key themes at the forefront of news today, such as leveraging the latest in machine learning to prepare for […]

Sword and Medexprim : combining clinical and imaging data in big-data research projects

October 12, 2017

Sword Group and Medexprim are partnering in view to offer cancer centers and large hospitals a unified solution to facilitate translational research, combining clinical and imaging data. SWORD GROUP has developed the innovative solution ConSoRe, in partnership with Unicancer, which federates 20 French leading not-for profit private cancer hospitals (« centres de lutte contre le cancer», http://www.unicancer.fr/unicancer) in France.  ConSoRe is an evolved […]

Focus on practical applications is stifling innovation, say 80% of surveyed chemistry professionals

September 27, 2017

Survey also shows a majority believe that expertise in working with digital tools is critical to career advancement  Chemistry is suffering due to its reputation for not being as innovative as other sciences, such as biology and physics, according to a survey of 186 industry professionals, carried out by Elsevier’s Reaxys team. 78% of chemists […]

Lysogene Launches World Class Clinical Advisory Board

September 13, 2017

PARIS & CAMBRIDGE, Mass.–(BUSINESS WIRE)–Regulatory News: Lysogene (FR0013233475 – LYS) (Paris:LYS), a leading biopharmaceutical company pioneering gene therapy technologies to treat central nervous system diseases, today announced the appointments of leading experts to its newly formed Clinical Advisory Board (CAB). The CAB will provide strategic advice to Lysogene as it continues to advance its clinical […]

The Future of RWE Technology-Moving Beyond Rapid Cycle Analytics

August 31, 2017

Rapid-cycle analytic technologies represent an important advance in the pursuit of improved evidence generation practices – but this is only the first step. Learn how RWE technology is evolving through standardization, efficiency, and democratization of data.

FDA Approval Brings First Gene Therapy to the United States

August 31, 2017

CAR T-cell therapy approved to treat certain children and young adults with B-cell acute lymphoblastic leukemia The U.S. Food and Drug Administration issued a historic action today making the first gene therapy available in the United States, ushering in a new approach to the treatment of cancer and other serious and life-threatening diseases. The FDA […]

Amgen Ventures Invests in GNS Healthcare to Advance Applications of its REFS Causal Machine Learning and Simulation AI Platforms

August 23, 2017

CAMBRIDGE, Mass., Aug. 23, 2017 /PRNewswire/ — GNS Healthcare (GNS), a leading precision medicine company, today announced that it has raised an additional $6 million in equity from Amgen Ventures with participation from existing investor Alexandria Real Estate Equities. The funds will be used to further develop the company’s REFS causal machine learning and simulation […]

Halloran Consulting Group Announces Role as US Regulatory Lead for Curtana Pharmaceuticals’ CT-179 Orphan Drug Designation for the Treatment of Gliomas

August 18, 2017

BOSTON, August 16, 2017 – Halloran Consulting Group, a national consultancy serving biotech, pharma, & medical device companies with clinical, quality and regulatory compliance projects, today announced their role as US regulatory consultants for Curtana Pharmaceuticals. The Food and Drug Administration (FDA) granted orphan drug designation to CT-179, Curtana Pharmaceuticals’ lead Olig2 inhibitor for the […]

NIH gives nod to Vibrent Health for precision medicine work

August 17, 2017

Vibrent Health’s cloud-based precision medicine platform has gained authority to operate from the National Institutes of Health, a certification that it meets federal privacy and security standards and paving the way for the company’s work on the landmark research cohort that will fuel the Precision Medicine Initiative   “This ATO certification marks a significant milestone […]

Is a shortage of bioinformaticians holding back adoption of precision therapies?

August 7, 2017

Many key scientists lack essential skills in bioinformatics and this is potentially a bottleneck for therapeutic research in big pharma. Dr Misha Kapushesky, CEO of Genestack, will discuss how increasing pressure on bioinformaticians is slowing the pace of discovery in a webinar ‘NGS: New Business Models in Diagnostics and Drug Development’ organised by Frost & […]

The Leukemia & Lymphoma Society (LLS) Announces Expansion of Groundbreaking Precision Medicine Approach to Fight Deadly Blood Cancer

July 20, 2017

RYE BROOK, N.Y., July 19, 2017 /PRNewswire-USNewswire/ –The Leukemia & Lymphoma Society (LLS) today announced the expansion of its groundbreaking precision medicine Beat AML® Master Trial, to test new, investigational treatments for acute myeloid leukemia (AML), the central initiative of LLS’s comprehensive assault on this deadly blood cancer affecting 20,000 Americans annually.   Launched in […]

Certara Endows Professorship at the UF College of Pharmacy

June 28, 2017

Certara®, the global leader in model-informed drug development and regulatory science, today announced that it has endowed a professorship at the University of Florida College of Pharmacy’s Center for Pharmacometrics and Systems Pharmacology. The professorship will strengthen the relationship between the college’s academic program and industry to drive innovation and enhance the application of leading-edge […]

Spearheading Stem Cell Innovations At The Stem Cells and Regenerative Medicine Global Summit

June 11, 2017

TORONTO, Canada, June 12, 2017 – Healthcare professionals, researchers and scientists from across research institutes, hospitals, biotechnology and pharmaceutical companies will gather at the inaugural Stem Cells and Regenerative Medicine Global Summit in Toronto, Canada from 25 – 27 September 2017, to discover development progress of stem cell medical treatments as well as to explore […]

FEEDBACK